Although there are controversies inthe analyzed studies, considering the possible benefits regarding breast cancerprevention and reduction in cardiovascular events, this systematic review suggeststhat therapy with selective estrogen receptor modulators and aspirin should bebetter investigated, and emphasizes the need for randomized trials. This evidence concerns the gene ESR1 and neoplasm.